Small vesicles as metabolic mediators

Small vesicles as metabolic mediators

  • Theresa V. Rohm
  • Felipe Castellani Gomes Dos Reis
  • Jerrold M. Olefsky
Article

Announcements

  • Healthy diet

    The editors at Nature Metabolism, in collaboration with the editors from Nature Communications,npj Metabolic Health and Disease and Scientific Reports invite submissions of original primary research papers that focus on preclinical and clinical (interventional or observational) studies assessing dietary patterns and interventions for improving cardiometabolic health.

    Open for submissions
  • Crossing arrows

    The Career Pathways series features the stories of Nature Metabolism authors and their self-professed journeys to publication as young investigators. This Collection brings together the Career Pathway pieces and the original research published in Nature Metabolism by the authors.

  • science lab

    This Collection highlights best practices in experimental design, analysis, and reporting to support the metabolic research community and increase reproducibility of research in the life sciences

  • Nature Conference announcement

    Nature Metabolism participates in the organization of a Nature Conference on the spatiotemporal regulation of metabolism. Topics covered include regulatory principles of subcellular and organismal metabolism, metabolic responses to lifestyle interventions, as well as metabolic alterations during ageing or cardiometabolic diseases. Join us in Wuhan in June 2024

Nature Metabolism is a Transformative Journal; authors can publish using the traditional publishing route OR via immediate gold Open Access.

Our Open Access option complies with funder and institutional requirements.

Advertisement

    • Angelika Rambold and Santiago Vernia reflect on how a very early interest in science has shaped their career, their research interests and their mentoring style.

      • Angelika Rambold
      • Santiago Vernia
      Viewpoint
    • Neurons have a high energy cost mainly sustained by glucose, but paradoxically present a weak glycolysis. This fact is now shown to account for healthy bioenergetics, reduced mitochondrial redox stress and whole-body fitness. Mice with high glycolytic rates in neurons present impaired autophagy, cognitive defects and metabolic-like syndrome.

      • Beatriz Pardo
      News & Views
    • Nguyen and Corvera review distinct changes that occur in adipose tissue during ageing, discuss potential mechanisms by which these changes impact whole-body metabolism, immunity and longevity, and highlight therapeutic opportunities.

      • Tammy T. Nguyen
      • Silvia Corvera
      Review Article
    • In an attempt to investigate the role of enteroendocrine cells in the colon using elegant, targeted depletion tools, the authors of a study published in this issue of Nature Metabolism highlight the orexigenic role of a bacterial metabolite in the intestinal lumen, l-glutamate.

      • Gwenola Le Dréan
      • Hervé M. Blottière
      News & Views
    • Agmatine produced by gut microbiota — specifically, Bacteroides vulgatus — activates the farnesoid X receptor (FXR) in intestinal epithelial L cells in a bile-acid-independent manner, which inhibits host glucagon peptide 1 (GLP-1) secretion and leads to polycystic ovary syndrome (PCOS) in mice. Supplementing mice with the GLP-1 receptor (GLP-1R) agonist liraglutide or inhibiting the production of agmatine reverses the PCOS phenotype.

      Research Briefing